Paper · 17599363
Optimal control of treatment in a mathematical model of chronic myelogenous leukemia.
Nanda S and 2 others. Math Biosci, 2007. Cited by 38 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Optimal control of treatment in a mathematical model of chronic myelogenous leukemia. Papers, record 17599363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17599363
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Major topic |
| Models, Biological | Major topic |
| Antigens, Neoplasm | |
| Antineoplastic Agents | |
| Benzamides | |
| Cytarabine | |
| Humans | |
| Imatinib Mesylate | |
| Mathematics | |
| Piperazines | |
| Pyrimidines | |
| T-Lymphocytes |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,955,091 | From forward-backward sweep to backpropagation for optimal control in tumor-immune dynamics. | J Math Biol | 2026 | https://conductscience.org/library/papers/42955091 | PubMed |
| 42,315,894 | Analysis of an SIR model: preventive measures, bounded multiplicative random perturbations and optimal control strategies. | Sci Rep | 2026 | https://conductscience.org/library/papers/42315894 | PubMed |
| 38,883,557 | Combination Chemotherapy Optimization with Discrete Dosing. | INFORMS J Comput | 2024 | https://conductscience.org/library/papers/38883557 | PubMed |
| 38,846,951 | Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms. | Front Immunol | 2024 | https://conductscience.org/library/papers/38846951 | PubMed |
| 38,427,689 | Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccine. | PLoS Comput Biol | 2024 | https://conductscience.org/library/papers/38427689 | PubMed |
| 36,561,665 | Modelling the impact of some control strategies on the transmission dynamics of Ebola virus in human-bat population: An optimal control analysis. | Heliyon | 2022 | https://conductscience.org/library/papers/36561665 | PubMed |
| 36,054,214 | Optimal anti-amyloid-beta therapy for Alzheimer's disease via a personalized mathematical model. | PLoS Comput Biol | 2022 | https://conductscience.org/library/papers/36054214 | PubMed |
| 35,601,872 | The Contribution of Evolutionary Game Theory to Understanding and Treating Cancer. | Dyn Games Appl | 2022 | https://conductscience.org/library/papers/35601872 | PubMed |
| 34,359,690 | Potential of Immunotherapies in Treating Hematological Cancer-Infection Comorbidities-A Mathematical Modelling Approach. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359690 | PubMed |
| 31,138,288 | The effects of time valuation in cancer optimal therapies: a study of chronic myeloid leukemia. | Theor Biol Med Model | 2019 | https://conductscience.org/library/papers/31138288 | PubMed |
1 to 10 of 23
See all 23 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17599363
GET https://conductscience.org/api/papers/v1/17599363/cited_by?page=2